Cargando…

Optimizing patient selection for stereotactic ablative radiotherapy in patients with locally advanced pancreatic cancer after initial chemotherapy - a single center prospective cohort

BACKGROUND: The role of stereotactic ablative radiation therapy (SABR) as local treatment option after chemotherapy for locally advanced pancreatic cancer (LAPC) is evolving. However adequate patient selection criteria for SABR in patients with LAPC are lacking. METHODS: A prospective institutional...

Descripción completa

Detalles Bibliográficos
Autores principales:	Doppenberg, D., Lagerwaard, F. J., van Dieren, S., Meijerink, M. R., van der Vliet, J. J., Besselink, M. G., van Tienhoven, G., Versteijne, E., Slotman, B. J., Wilmink, J. W., Kazemier, G., Bruynzeel, A. M. E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264658/ https://www.ncbi.nlm.nih.gov/pubmed/37324027 http://dx.doi.org/10.3389/fonc.2023.1149961

Ejemplares similares

Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
por: Doppenberg, D., et al.
Publicado: (2022)

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design
por: Doppenberg, D., et al.
Publicado: (2023)

Renal atrophy following gated delivery of stereotactic ablative radiotherapy to adrenal metastases
por: van Sörnsen de Koste, John R., et al.
Publicado: (2021)

Clinical outcomes of MR-guided adrenal stereotactic ablative radiotherapy with preferential sparing of organs at risk
por: Schneiders, Famke L., et al.
Publicado: (2023)

The Role of Daily Adaptive Stereotactic MR-Guided Radiotherapy for Renal Cell Cancer
por: Tetar, Shyama U., et al.
Publicado: (2020)

The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer
por: Zwart, Eline S., et al.
Publicado: (2023)

Same-day consultation, simulation and lung Stereotactic Ablative Radiotherapy delivery on a Magnetic Resonance-linac
por: Palacios, Miguel A., et al.
Publicado: (2022)

Meta‐analysis comparing upfront surgery with neoadjuvant treatment in patients with resectable or borderline resectable pancreatic cancer
por: Versteijne, E., et al.
Publicado: (2018)

Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer
por: Tetar, Shyama U., et al.
Publicado: (2019)

Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancer
por: Verstegen, Naomi E., et al.
Publicado: (2016)

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy or Stereotactic Radiotherapy?
por: van Dorp, Martijn, et al.
Publicado: (2023)

Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3–5 cm) Unresectable Colorectal Liver Metastases: a Systematic Review and Meta-analysis
por: Nieuwenhuizen, Sanne, et al.
Publicado: (2022)

A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE)
por: van Goor, I. W. J. M., et al.
Publicado: (2022)

Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)

Correction: A nationwide randomized controlled trial on additional treatment for isolated local pancreatic cancer recurrence using stereotactic body radiation therapy (ARCADE)
por: van Goor, I. W. J. M., et al.
Publicado: (2023)

Unresectable Intermediate-Size (3–5 cm) Colorectal Liver Metastases: Stereotactic Ablative Body Radiotherapy Versus Microwave Ablation (COLLISION-XL): Protocol of a Phase II/III Multicentre Randomized Controlled Trial
por: van der Lei, Susan, et al.
Publicado: (2023)

Magnetic resonance imaging-guided radiotherapy for intermediate- and high-risk prostate cancer: Trade-off between planning target volume margin and online plan adaption
por: Tetar, Shyama U., et al.
Publicado: (2022)

The clinical introduction of MR-guided radiation therapy from a RTT perspective
por: Botman, R., et al.
Publicado: (2019)

Ablation with irreversible electroporation in patients with advanced perihilar cholangiocarcinoma (ALPACA): a multicentre phase I/II feasibility study protocol
por: Coelen, Robert J S, et al.
Publicado: (2017)

A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer
por: Underberg, René WM, et al.
Publicado: (2006)

Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function
por: Senger, C., et al.
Publicado: (2019)

The role of biological dose-escalation for pancreatic cancer
por: Bruynzeel, Anna M.E., et al.
Publicado: (2019)

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases
por: Hartgerink, Dianne, et al.
Publicado: (2021)

Thermal Ablation versus Stereotactic Ablative Body Radiotherapy to Treat Unresectable Colorectal Liver Metastases: A Comparative Analysis from the Prospective Amsterdam CORE Registry
por: Nieuwenhuizen, Sanne, et al.
Publicado: (2021)

Pitfalls of Ovarian Ablative Magnetic Resonance-guided Radiation Therapy for Refractory Endometriosis
por: Tetar, Shyama, et al.
Publicado: (2018)

Feasibility of Proton Transmission-Beam Stereotactic Ablative Radiotherapy versus Photon Stereotactic Ablative Radiotherapy for Lung Tumors: A Dosimetric and Feasibility Study
por: Mou, Benjamin, et al.
Publicado: (2014)

Stereotactic ablative body radiotherapy in patients with prostate cancer
por: Loblaw, Andrew, et al.
Publicado: (2018)

Stereotactic ablative radiotherapy in patients with refractory ventricular tachyarrhythmia
por: Molon, Giulio, et al.
Publicado: (2022)

Added Value of Radiotherapy Following Neoadjuvant FOLFIRINOX for Resectable and Borderline Resectable Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Janssen, Quisette P., et al.
Publicado: (2021)

Delivery of magnetic resonance-guided single-fraction stereotactic lung radiotherapy
por: Finazzi, Tobias, et al.
Publicado: (2020)

Advances in Radiobiology of Stereotactic Ablative Radiotherapy
por: Qiu, Bin, et al.
Publicado: (2020)

The Confluence of Stereotactic Ablative Radiotherapy and Tumor Immunology
por: Finkelstein, Steven Eric, et al.
Publicado: (2011)

Fatigue and radiotherapy: (A) experience in patients undergoing treatment.
por: Smets, E. M., et al.
Publicado: (1998)

Clinical outcomes of patients with duodenal adenocarcinoma and intestinal-type papilla of Vater adenocarcinoma
por: Meijer, Laura L, et al.
Publicado: (2020)

Patient-reported Outcome Measurements on the Tolerance of Magnetic Resonance Imaging-guided Radiation Therapy
por: Tetar, Shyama, et al.
Publicado: (2018)

Liver Stereotactic Ablative Radiotherapy: an Effective and Feasible Alternative to Surgery during the COVID-19 Pandemic
por: Aitken, K., et al.
Publicado: (2020)

Stereotactic ablative radiotherapy for oligometastatic breast cancer in elderly patients
por: Morales-Orue, Ignacio, et al.
Publicado: (2020)

Commissioning and initial stereotactic ablative radiotherapy experience with Vero
por: Solberg, Timothy D., et al.
Publicado: (2014)

Adaptive Magnetic Resonance-Guided Stereotactic Body Radiotherapy: The Next Step in the Treatment of Renal Cell Carcinoma
por: Keller, Brian, et al.
Publicado: (2021)

Stereotactic Ablative Radiotherapy for Oligometastatic Disease in Liver
por: Kim, Myungsoo, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_7tuchh5c95gk7du856crbb3ajh